4
Changes in Ownership
Alaunos Therapeutics, Inc. Filed Acc 0001209191-17-000996
Chief Executive Officer gave up 17,292 shares (to pay taxes)
- Chief Executive Officer acquired 212,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Cooper Laurence James Neil Chief Executive Officer | 2016-12-30 | Grant or award | +212,250 | 1,226,583 | D | ||
| Cooper Laurence James Neil Chief Executive Officer | 2016-12-31 | Shares withheld for taxes | −17,292 | $5.35 | $92,512 | 1,209,291 | D |
Loading xslF345X03/doc4.xml…